Article
Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL.
Pharmacogenomics - 1 Jul 2012
Dorababu Patchva, Naushad Shaik Mohammad, Linga Vijay Gandhi, Gundeti Sadashivudu, Nagesh Narayana, Kutala Vijay Kumar, Reddanna Pallu, Digumarti Raghunadharao
Abstract excerpt
AIM: The rationale of this study was to explore the contribution of genetic variants of the folate pathway to toxicity of 6-mercaptopurine (6-MP)-mediated hematological toxicity in children with acute lymphoblastic leukemia (ALL) and to explore the interaction of these variants with TPMT and ITPA haplotypes using multifactor dimensionality reduction analysis. MATERIALS & METHODS: Children with ALL (n = 96) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
